OM - Outset Medical, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
San Jose,
United States
Type: Equity
OM price evolution
OM
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $71.84 | $39.63 | $39.72 | $39.7 |
| Short term investments | $134.81 | $157.7 | $186.4 | $212.83 |
| Net receivables | $32.98 | $35.49 | $36.9 | $34.31 |
| Inventory | $49.22 | $48.26 | $44.49 | $47.73 |
| Total current assets | $291.22 | $283.77 | $309.4 | $337.27 |
| Long term investments | ||||
| Property, plant & equipment | $18.65 | $19.49 | $20.58 | $21.01 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $22.58 | $23.78 | $25.04 | $25.39 |
| Total investments | $134.81 | $157.7 | $186.4 | $212.83 |
| Total assets | $313.8 | $307.55 | $334.44 | $362.67 |
| Current liabilities | ||||
| Accounts payable | $5.83 | $2.88 | $2.22 | $1.99 |
| Deferred revenue | $11.83 | $10.93 | $10.94 | $9.15 |
| Short long term debt | $1.59 | $1.54 | $1.47 | $1.36 |
| Total current liabilities | $55.32 | $53.02 | $48.82 | $44.27 |
| Long term debt | $134.59 | $101.69 | $101.94 | $101.7 |
| Total noncurrent liabilities | $135.59 | $102.46 | $102.51 | $102.11 |
| Total debt | $136.19 | $103.23 | $103.41 | $103.06 |
| Total liabilities | $190.91 | $155.49 | $151.33 | $146.38 |
| Shareholders' equity | ||||
| Retained earnings | -$961.75 | -$923.15 | -$876.97 | -$832.92 |
| Other shareholder equity | $0.07 | -$0.25 | -$0.39 | -$0.11 |
| Total shareholder equity | $122.89 | $152.06 | $183.11 | $216.29 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $71.84 | $76.53 | $215.66 | $328.28 |
| Short term investments | $134.81 | $214.28 | $157.14 | $19.9 |
| Net receivables | $32.98 | $28.07 | $25.6 | $6.47 |
| Inventory | $49.22 | $51.48 | $39.19 | $18.38 |
| Total current assets | $291.22 | $373.64 | $409.8 | $345.91 |
| Long term investments | ||||
| Property, plant & equipment | $18.65 | $21.99 | $20.2 | $23.25 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $22.58 | $26.47 | $53.66 | $57.92 |
| Total investments | $134.81 | $214.28 | $157.14 | $19.9 |
| Total assets | $313.8 | $400.12 | $463.46 | $403.83 |
| Current liabilities | ||||
| Accounts payable | $5.83 | $0.6 | $1.76 | $4.95 |
| Deferred revenue | $11.83 | $8.81 | $6.65 | $3.77 |
| Short long term debt | $1.59 | $1.32 | $1.15 | $0.88 |
| Total current liabilities | $55.32 | $51.95 | $51.7 | $36.69 |
| Long term debt | $134.59 | $96.34 | $36.66 | $37.72 |
| Total noncurrent liabilities | $135.59 | $102.18 | $37.69 | $38.53 |
| Total debt | $136.19 | $103.23 | $37.81 | $38.6 |
| Total liabilities | $190.91 | $154.13 | $89.38 | $75.22 |
| Shareholders' equity | ||||
| Retained earnings | -$961.75 | -$788.95 | -$625.99 | -$494.06 |
| Other shareholder equity | $0.07 | -$0.56 | -$0.18 | $0 |
| Total shareholder equity | $122.89 | $245.99 | $374.08 | $328.61 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $30.51 | $30.36 | $36.04 | $33.47 |
| Cost of revenue | $22.8 | $23.2 | $28.34 | $27.04 |
| Gross Profit | $7.71 | $7.16 | $7.7 | $6.43 |
| Operating activities | ||||
| Research & development | $12.53 | $16.08 | $14.91 | $13.79 |
| Selling, general & administrative | $32.53 | $36.53 | $36.27 | $36.12 |
| Total operating expenses | $45.06 | $52.61 | $51.18 | $49.91 |
| Operating income | -$37.35 | -$45.45 | -$43.48 | -$43.48 |
| Income from continuing operations | ||||
| EBIT | -$35.07 | -$42.88 | -$40.81 | -$40.84 |
| Income tax expense | $0.11 | $0.09 | $0.13 | $0.19 |
| Interest expense | $3.42 | $3.21 | $3.1 | $2.94 |
| Net income | ||||
| Net income | -$38.6 | -$46.18 | -$44.05 | -$43.97 |
| Income (for common shares) | -$38.6 | -$46.18 | -$44.05 | -$43.97 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $130.38 | $115.38 | $102.6 | $49.94 |
| Cost of revenue | $101.38 | $97.54 | $94.99 | $62.97 |
| Gross Profit | $29 | $17.83 | $7.61 | -$13.04 |
| Operating activities | ||||
| Research & development | $57.31 | $48.85 | $36.74 | $28.85 |
| Selling, general & administrative | $141.46 | $130 | $101.39 | $75.58 |
| Total operating expenses | $198.77 | $178.85 | $138.13 | $104.43 |
| Operating income | -$169.77 | -$161.02 | -$130.52 | -$117.47 |
| Income from continuing operations | ||||
| EBIT | -$159.6 | -$159.09 | -$130.02 | -$118.6 |
| Income tax expense | $0.52 | $0.29 | $0.2 | |
| Interest expense | $12.68 | $3.57 | $1.72 | $2.89 |
| Net income | ||||
| Net income | -$172.8 | -$162.96 | -$131.94 | -$121.49 |
| Income (for common shares) | -$172.8 | -$162.96 | -$131.94 | -$79.32 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$38.6 | -$46.18 | -$44.05 | -$43.97 |
| Operating activities | ||||
| Depreciation | $1.8 | $1.78 | $1.82 | $1.68 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $9.1 | $10.89 | $10.11 | $8.54 |
| Total cash flows from operations | -$24.44 | -$34 | -$28.18 | -$44.76 |
| Investing activities | ||||
| Capital expenditures | -$1.05 | -$0.78 | -$0.8 | -$0.81 |
| Investments | $24.48 | $30.59 | $27.95 | $3.45 |
| Total cash flows from investing | $23.43 | $29.8 | $27.15 | $2.64 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $4.1 | $1.04 | $5.28 |
| Net borrowings | $33.23 | |||
| Total cash flows from financing | $33.23 | $4.1 | $1.04 | $5.28 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $32.21 | -$0.09 | $0.02 | -$36.84 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$172.8 | -$162.96 | -$131.94 | -$121.49 |
| Operating activities | ||||
| Depreciation | $7.08 | $6.28 | $6.18 | $3.75 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $38.63 | $27.2 | $17.45 | $21.44 |
| Total cash flows from operations | -$131.37 | -$145.73 | -$130.26 | -$99.02 |
| Investing activities | ||||
| Capital expenditures | -$3.44 | -$8.32 | -$3.11 | -$9.08 |
| Investments | $86.47 | -$57.97 | -$139.4 | $13.02 |
| Total cash flows from investing | $83.03 | -$66.3 | -$142.51 | $3.95 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.43 | $8.04 | $160.15 | $256 |
| Net borrowings | $33.23 | $64.86 | -$1.36 | |
| Total cash flows from financing | $43.65 | $72.9 | $160.15 | $385.68 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$4.7 | -$139.13 | -$112.62 | $290.61 |
News
Fundamentals
| Market cap | $108.68M |
|---|---|
| Enterprise value | $173.03M |
| Shares outstanding | 50.32M |
| Revenue | $130.38M |
|---|---|
| EBITDA | -$152.52M |
| EBIT | -$159.60M |
| Net Income | -$172.80M |
| Revenue Q/Q | -4.69% |
| Revenue Y/Y | N/A |
| P/E ratio | -0.63 |
|---|---|
| EV/Sales | 1.33 |
| EV/EBITDA | -1.13 |
| EV/EBIT | -1.08 |
| P/S ratio | 0.83 |
| P/B ratio | 0.88 |
| Book/Share | 2.44 |
| Cash/Share | 1.43 |
| EPS | -$3.43 |
|---|---|
| ROA | -52.42% |
| ROE | -102.50% |
| Debt/Equity | 1.55 |
|---|---|
| Net debt/EBITDA | -0.78 |
| Current ratio | 5.26 |
| Quick ratio | 4.37 |